<DOC>
	<DOCNO>NCT02467517</DOCNO>
	<brief_summary>The primary outcome compare analgesic efficacy intravenous ketamine treatment placebo patient refractory neuropathic pain . The secondary outcome : 1 . - To compare additive analgesic efficacy prior administration magnesium sulfate placebo ketamine , effectiveness intravenous ketamine treatment , 2 . - To study evolution time pain analgesia intravenous administration ketamine placebo , 3 . - To study correlation analgesic response administer product respectively ketamine , ketamine magnesium sulfate , placebo .</brief_summary>
	<brief_title>Ketamine Neuropathic Pain</brief_title>
	<detailed_description>Description study : Single-center clinical trial , control , randomize , double-blind , crossover design , inactive placebo . Each patient receive successively 3 product ( ketamine / placebo , ketamine / magnesium sulfate , placebo / placebo ) follow predeter randomization list , wash-out period administration . Visit 1 -Inclusion visit , signature inform consent form , clinical examination fill questionnaire . For woman childbearing age pregnancy test performed.The pain measure numerical scale . The pain evaluate score numerical scale . A booklet monitoring analgesic concomitant medication overall pain numerical scale give patient 14 day program infusion . Visit 2 : Period 1 Day 0 Clinical examination , return booklet complete patient fill questionnaire . The pain evaluate score numerical scale infusion . For woman childbearing age pregnancy test perform . Treatment allocation period follow predeter randomization list . At end infusion , booklet monitoring give patient follow week order score overall pain next study period . The output hospital patient ( CPC / CETD ) treatment authorize investigator . Wash-out period : 5 week . Phone call 1 ( Day 1 ) : Patients call phone collect adverse event concomitant medication . If necessary , patient return consult CPC / CETD clinical examination . Patients call week schedule visit , time spontaneous pain still low , accord opinion investigator , infusion visit shift allow pain level back basal level . Visit 3 : Period 2 : Day 36 +/- 3 day Same period 1 . Phone call 2 J 37 +/- 3 day : Same phone call 1 . Visit 4 : Period 3 : Day 72 +/- 3 day Same period 1 Phone call 3 J 73 +/- 3 day : Same phone call 1 . Visit 5 : Day 108 +/- 3 day Clinical examination , return booklet complete patient fill questionnaire . The pain evaluate score numerical scale For woman childbearing age pregnancy test perform . This visit end study .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Patient ( ) least18 year old , chronic pain ( 3 month ) , characteristic peripheral central neuropathy , follow ( ) Pain Clinic CHU ClermontFerrand justify establishment therapeutic program include intravenous infusion ketamine ( therapeutic test ) ; Patient ( ) never receive ketamine infusion care neuropathic pain ; History illness compatible injury disease somatosensory system ; Localized pain anatomical neuro territory ; Neurological examination show sensory abnormality , The patient childbearing potential must use effective contraception throughout study ; For woman childbearing age , enrol study negative urine pregnancy test ; case suspicion pregnancy , blood pregnancy test perform ; Cooperation willing follow study ; Acceptance give write consent ; Affiliated French social security ; Inscription acceptation inscription national register volunteer involve trial . Patient ( ) receive intravenous ketamine infusion ; Patients one many contraindication ketamine administration : know hypersensitivity ketamine one constituent product , uncontrolled high blood pressure , severe cardiac insufficiency ; Patients one many contraindication magnesium sulfate administration : Patients severe renal impairment ; Patients one many contraindication administration sodium chloride : water inflation , fluid retention ; Patients medical history / surgical judge investigator consistent clinical trial ; Patients drug treatment judge investigator consistent clinical trial ; Pregnancy lactation woman ; Patient participate another clinical trial , locate exclusion period receive benefit &gt; 4500 euro 12 month begin trial ; Patients cooperation understand adhere strictly condition provide clinical trial ; Patients receive measure legal protection ( guardianshipâ€¦ ) ; Patients affiliate System French Social Security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Neuropathic pain</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Magnesium sulfate</keyword>
	<keyword>Quality life</keyword>
	<keyword>Anxiety depression</keyword>
	<keyword>Mood sleep</keyword>
</DOC>